Journal article

Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington's disease

Pineda J, Pardo R, Zala D, Yu H, Humbert S, Saudou F ...see all

Molecular Brain, vol. 2, issue 1 (2009) p. 33

  • 47

    Readers

    Mendeley users who have this article in their library.
  • Citations

    Citations of this article.
  • Views

    ScienceDirect users who have downloaded this article.
Sign in to save reference

Abstract

Huntington's disease (HD) is an inherited neurogenerative disease caused by an abnormal expansion of glutamine repeats in the huntingtin protein. There is currently no treatment to prevent the neurodegeneration caused by this devastating disorder. Huntingtin has been shown to be a positive regulator of vesicular transport, particularly for neurotrophins such as brain-derived neurotrophic factor (BDNF). This function is lost in patients with HD, resulting in a decrease in neurotrophic support and subsequent neuronal death. One promising line of treatment is therefore the restoration of huntingtin function in BDNF transport.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text

Authors

  • Jose R Pineda

  • Raúl Pardo

  • Diana Zala

  • Hua Yu

  • Sandrine Humbert

  • Frédéric Saudou

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free